1891; series 3: 923-957. 16. Rivitti, EA. Alopecia areata: revisao e atualizacao. An. Bras. Dermatol. 2005; 80(1):57-68.17. Paus R, Muller-Rover S, Van Der Veen C, Maurer M, Eichmuller S, Ling G, Hofmann U, Foitzik K, Mecklenburg L, Handjiski B. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol. 1999 Oct; 113(4):523-32. 18. Pinkus H. Embryology of hair. In: The biology of hair growth. Montagna W, Ellis RA (eds). Academic Press Inc, New York, 1958, pp 1-32. 19. Van Scott EJ. Morphologic changes in pilosebaceous units and anagen hairs in alopecia areata. J Invest Dermatol 1958; 31: 35-43.20. Chase HB. Growth of the hair. Physiol Revs. 1954; 34: 113-126.21. Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 1984; 83: 7-11. 22. Perret C, Weisner-Menzel L, Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venerol 1984; 64: 26-30. 23. Eckert J, Church RE, Ebling FJ. The pathogenesis of alopecia areata. Br J Dermatol. 1968 Apr; 80(4):203-10.24. Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol. 1985 Dec; 85(6):569-72.25. Van Scott EJ. Evaluation of disturbed hair growth in alopecia areata and other alopecias. Ann NY Acad Sci 1959; 83: 480-490. 26. Swanson NA, Mitchell AJ, Leahy MS, Headington JT, Diaz LA. Topical treatment of alopecia areata. Arch Dermatol. 1981 Jul; 117(7):384-7.27. Gollinck H, Orfanos CE: Alopecia areata: pathogenesis and clinical picture. In: Orfanos CE, Happle R, eds. Hair and Hair Diseases. Berlin: Springer-Verlag, 1990: 529-69. 28. Rook A. Disorders of the hair. Practitioner. 1973 Nov; 211(265):593-99.29. The Third International Research Workshop on Alopecia Areata was held in Washington DC on the 5th November 1998 at the Renaissance Mayflower Hotel. The conference was organized jointly by the National Alopecia Areata Foundation and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) which is part of the National Institutes of Health (NIH).30. Vogel F, Motulsky AG. Human Genetics: problems and approaches. 3rd Edition. Berlin: Springer-Verlag, 1997: 223-6. 31. Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol. 1985 Dec; 85(6):569-72. 32. Brocker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol. 1987 May; 88(5):564-8.33. Du Vivier A, Munro DD. Alopecia areata, autoimmunity, and Downs syndrome. Br Med J. 1975 Jan 25; 1(5951):191-2. 34. Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct; 112(10):1397-9. 35. Wunderlich C, Braun-Falco O. Mongolismus und alopecia areata. Med Welt 1965; 10: 477-81. 36. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy. Nat Genet. 1997 Dec; 17(4):399-403. 37. Betterle C, Greggio NA, Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J